Compounds and methods for targeting interleukin 34

The present disclosure relates to IL-34 antibodies, compositions comprising the antibodies, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or tauopathy. 本公开涉及IL-34抗体、包...

Full description

Saved in:
Bibliographic Details
Main Authors SCOLA, ANDREW, DAVID, MINTHONG MILIND, WEST ERIC ANTHONY, LOO ALEXANDER, SIMS, JOHN, R., II, WALSH, RICHARD, E, CHEAD MICHAEL, FLEISCHER AMY S, RANNAN MANISH BABU, RAINES, SCOTT, E, OBUNGU VICTOR H, YE, MING
Format Patent
LanguageChinese
English
Published 20.08.2024
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present disclosure relates to IL-34 antibodies, compositions comprising the antibodies, and methods of using the antibodies and or compositions thereof for the treatment of immune-mediated diseases, such as neurodegenerative diseases, such as Alzheimer's disease or tauopathy. 本公开涉及IL-34抗体、包含该抗体的组合物以及使用该抗体和或其组合物用于治疗免疫介导的疾病例如神经退行性疾病,例如阿尔茨海默氏病或tau蛋白病的方法。
Bibliography:Application Number: CN20228086947